cGKII Antibodies

Santa Cruz Biotechnology provides a broad selection of cGKII monoclonal antibodies for research focused on cyclic GMP-dependent protein kinase II (cGKII) in various biological processes. cGKII monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). cGKII plays a crucial role in mediating the effects of cyclic GMP, influencing processes such as smooth muscle relaxation, neuronal signaling, and cellular proliferation. The significance of cGKII in cardiovascular health and its potential implications in various diseases make it a key target for scientific investigation. Research focused on cGKII function can reveal new therapeutic strategies for conditions related to its dysregulation. cGKII Antibodies targeting cGKII enable precise detection and analysis of protein expression, localization, and interactions. Understanding cGKII mechanisms and pathways contributes to advancing knowledge in cell signaling and regulation. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of cGKII's role in health and disease.